The INSPIRE study: Are different personality traits related to disease-specific quality of life (IBDQ) in distressed patients with ulcerative colitis and Crohn's disease?

Inflammatory Bowel Diseases

Volumn 14, Issue 5, 2008, Pages 680-686

  Boye, Birgitte ^a,b   Johnsen, Jorgen ^c   Mokleby, Kjell ^b   Leganger, Siv ^b   Jantschek, Günter ^d   Jantschek, Ingrid ^d   Kunzendorf, Sebastian ^d   Benninghoven, Dieter ^d   Wilhelmsen, Ingvard ^e,f   Sharpe, Michael ^g   Blomhoff, Svein ^b   Malt, Ulrik F ^a,b   Lundin, Knut E A ^a,b  

^a UNIVERSITY OF OSLO   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c AKER UNIVERSITY HOSPITAL   (Norway)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^e UNIVERSITY OF BERGEN   (Norway)

^f Haraldsplass Deaconal Hospital   (Norway)

^g UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Crohn's disease; Inflammatory bowel disease; Personality; Quality of life; Ulcerative colitis

Indexed keywords

ADULT; AGGRESSION; ALEXITHYMIA; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; HOSTILITY; HUMAN; LINEAR REGRESSION ANALYSIS; LOCUS OF CONTROL; MAJOR CLINICAL STUDY; MALE; PERSONALITY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; RELAPSE; SOCIAL PSYCHOLOGY; ULCERATIVE COLITIS;

ADOLESCENT; ADULT; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NEUROTIC DISORDERS; PERSONALITY; PROGNOSIS; QUALITY OF LIFE; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STRESS, PSYCHOLOGICAL;

EID: 44349166913     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20367     Document Type: Article

References (60)

1. Moum B, Vatn MH, Ekbom A, et al. Incidence of ulcerative colitis and indeterminate colitis in four counties of southeastern Norway, 1990-93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists. Scand J Gastroenterol. 1996;31:362-366.
2. Moum B, Vatn MH, Ekbom A, et al. Incidence of Crohn's disease in four counties in southeastern Norway, 1990-93. A prospective population-based study. The Inflammatory Bowel South-Eastern Norway (IBSEN) Study Group of Gastroenterologists. Scand J Gastroenterol. 1996;31:355-361.
3. Irvine EJ. Development and subsequent refinement of the inflammatory bowel disease questionnaire: a quality-of-life instrument for adult patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 1999;28:S23-S27.
4. Guyatt G, Mitchell A, Irvine EJ, et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology. 1989;96:804-810.
5. Hlavaty T, Persoons P, Vermeire S, et al. Evaluation of short-term responsiveness and cutoff values of inflammatory bowel disease questionnaire in Crohn's disease. Inflamm Bowel Dis. 2006;12:199-204.
6. Rutgeerts P, Sandborn WJ, Feagan BG, et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med. 2005;353:2462-2476.
7. Sandborn WJ, Feagan BG, Hanauer SB, et al. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. Gastroenterology. 2002;122:512-530.
8. Casellas F, Arenas JI, Baudet JS, et al. Impairment of health-related quality of life in patients with inflammatory bowel disease: a Spanish multicenter study. Inflamm Bowel Dis. 2005;11:488-496.
9. Bernklev T, Jahnsen J, Aadland E, et al. Health-related quality of life in patients with inflammatory bowel disease five years after the initial diagnosis. Scand J Gastroenterol. 2004;39:365-373.
10. Sainsbury A, Heatley RV. Review article: psychosocial factors in the quality of life of patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2005;21:499-508.
11. Moreno-Jimenez B, Lopez BB, Rodriguez-Munoz A, et al. The influence of personality factors on health-related quality of life of patients with inflammatory bowel disease. J Psychosom Res. 2007;62:39-46.
12. Verissimo R, Mota-Cardoso R, Taylor G. Relationships between alexithymia, emotional control, and quality of life in patients with inflammatory bowel disease. Psychother Psychosom. 1998;67:75-80.
13. ENGEL GL. Studies of ulcerative colitis. III. The nature of the psychologic processes. Am J Med. 1955;19:231-256.
14. Gerbert B. Psychological aspects of Crohn's disease. J Behav Med. 1980;3:41-58.
15. Holder EE, Levi DJ. Mental health and locus of control: SCL-90-R and Levenson's IPC scales. J Clin Psychol. 1988;44:753-755.
16. Raja SN, Williams S, McGee R. Multidimensional health locus of control beliefs and psychological health for a sample of mothers. Soc Sci Med. 1994;39:213-220.
17. Ondersma SJ, Lumley MA, Corlis ME, et al. Adolescents with inflammatory bowel disease: the roles of negative affectivity and hostility in subjective versus objective health. J Pediatr Psychol. 1997;22:723-738.
18. Miller TQ, Markides KS, Chiriboga DA, et al. A test of the psychosocial vulnerability and health behavior models of hostility: results from an 11-year follow-up study of Mexican Americans. Psychosom Med. 1995;57:572-581.
19. Levenstein S, Prantera C, Varvo V, et al. Stress and exacerbation in ulcerative colitis: a prospective study of patients enrolled in remission. Am J Gastroenterol. 2000;95:1213-1220.
20. Vidal A, Gomez-Gil E, Sans M, et al. Life events and inflammatory bowel disease relapse: a prospective study of patients enrolled in remission. Am J Gastroenterol. 2006;101:775-781.
21. Bitton A, Sewitch MJ, Peppercorn MA, et al. Psychosocial determinants of relapse in ulcerative colitis: a longitudinal study. Am J Gastroenterol. 2003;98:2203-2208.
22. Mittermaier C, Dejaco C, Waldhoer T, et al. Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study. Psychosom Med. 2004;66:79-84.
23. Harvey RF, Bradshaw JM. A simple index of Crohn's-disease activity. Lancet. 1980;1:514.
24. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ. 1989;298:82-86.
25. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatrie Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22-33.
26. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382-389.
27. Levenstein S, Prantera C, Varvo V, et al. Development of the Perceived Stress Questionnaire: a new tool for psychosomatic research. J Psychosom Res. 1993;37:19-32.
28. Bernklev T, Moum B, Moum T. Quality of life in patients with inflammatory bowel disease: translation, data quality, scaling assumptions, validity, reliability and sensitivity to change of the Norwegian version of IBDQ. Scand J Gastroenterol. 2002;37:1164-1174.
29. Janke KH, Steder-Neukamm U, Bauer M, et al. [Quality of life assessment in Inflammatory Bowel Disease (IBD): German version of the Inflammatory Bowel Disease Questionnaire (IBDQ-D; disease-specific instrument for quality of life assessment) - first application and comparison with international investigations]. Gesundheitswesen. 2005;67:656-664.
30. Janke KH, Klump B, Steder-Neukamm U, et al. [Validation of the German version of the Inflammatory Bowel Disease Questionnaire (Competence Network IBD, IBDQ-D)]. Psychother Psychosom Med Psychol. 2006;56:291-298.
31. Buss AH, Perry M. The aggression questionnaire. J Pers Soc Psychol. 1992;63:452-459.
32. Wallston KA, Wallston BS, DeVellis R. Development of the Multidimensional Health Locus of Control (MHLC) Scales. Health Educ Monogr. 1978;6:160-170.
33. Taylor GJ, Ryan D, Bagby RM. Toward the development of a new self-report alexithymia scale. Psychother Psychosom. 1985;44:191-199.
34. Taylor GJ, Bagby RM, Ryan DP, et al. Criterion validity of the Toronto Alexithymia Scale. Psychosom Med. 1988;50:500-509.
35. Eysenck HJ, Eysenck SG B. The Manual of the Eysenck Personality Questionnaire. London: Hodder & Stoughton; 1975.
36. Harris JA. A further evaluation of the Aggression Questionnaire: issues of validity and reliability. Behav Res Ther. 1997;35:1047-1053.
37. Talbot F, Nouwen A, Gauthier J. Is health locus of control a 3-factor or a 2-factor construct? J Clin Psychol. 1996;52:559-568.
38. Wallston KA. The validity of the multidimensional health locus of control scales. J Health Psychol. 2005;10:623-631.
39. Bagby RM, Taylor GJ, Parker JD, et al. Cross-validation of the factor structure of the Toronto Alexithymia Scale. J Psychosom Res. 1990;34:47-51.
40. Burgess AP, Carretero M, Elkington A, et al. The role of personality, coping style and social support in health-related quality of life in HIV infection. Qual Life Res. 2000;9:423-437.
41. Westlake C, Dracup K, Creaser J, et al. Correlates of health-related quality of life in patients with heart failure. Heart Lung. 2002;31:85-93.
42. O'Carroll RE, Couston M, Cossar J, et al. Psychological outcome and quality of life following liver transplantation: a prospective, national, single-center study. Liver Transpl. 2003;9:712-720.
43. Schou I, Ekeberg O, Sandvik L, et al. Multiple predictors of health-related quality of life in early stage breast cancer. Data from a year follow-up study compared with the general population. Qual Life Res. 2005;14:1813-1823.
44. van den Berg MP, Ranchor AV, van Sonderen FL, et al. Paroxysmal atrial fibrillation, quality of life and neuroticism. Neth J Med. 2005;63:170-174.
45. Vandvik PO, Wilhelmsen I, Ihlebaek C, et al. Comorbidity of irritable bowel syndrome in general practice: a striking feature with clinical implications. Aliment Pharmacol Ther. 2004;20:1195-1203.
46. Yamaoka K, Shigehisa T, Ogoshi K, et al. Health-related quality of life varies with personality types: a comparison among cancer patients, non-cancer patients and healthy individuals in a Japanese population. Qual Life Res. 1998;7:535-544.
47. Zhang SJ, Huang LH, Wen YL, et al. Impact of personality and coping mechanisms on health related quality of life in liver transplantation recipients. Hepatobiliary Pancreat Dis Int. 2005;4:356-359.
48. Macaskill GT, Hopper JL, White V, et al. Genetic and environmental variation in Eysenck Personality Questionnaire scales measured on Australian adolescent twins. Behav Genet. 1994;24:481-491.
49. Wilhelmsen I, Berstad A. Reduced relapse rate in duodenal ulcer disease leads to normalization of psychological distress: twelve-year follow-up. Scand J Gastroenterol. 2004;39:717-721.
50. Watson D, Clark LA. On traits and temperament: general and specific factors of emotional experience and their relation to the five-factor model. J Pers. 1992;60:441-476.
51. Jacobs N, Kenis G, Peeters F, et al. Stress-related negative affectivity and genetically altered serotonin transporter function: evidence of synergism in shaping risk of depression. Arch Gen Psychiatry. 2006;63:989-996.
52. Kugler J, Tenderich G, Stahlhut P, et al. Emotional adjustment and perceived locus of control in heart transplant patients. J Psychosom Res. 1994;38:403-408.
53. Levenson H. Differentiation among internality, powerful others, and chance. In: Lefcourt HM, ed. Research with the Locus of Control Construct. New York: Academic Press; 1981:15-63.
54. Levenson H. Multidimensional locus of control in psychiatric patients. J Consult Clin Psychol. 1973;41:397-404.
55. Wallston KA, Wallston BS. Health locus of control scales. In: Lefcourt HM, ed. Research with the Locus of Control Construct. New York: Academic Press; 1981:189-243.
56. Newsom JT, Knapp JE, Schulz R. Longitudinal analysis of specific domains of internal control and depressive symptoms in patients with recurrent cancer. Health Psychol. 1996;15:323-331.
57. Taylor GJ, Bagby RM, Parker JD. The 20-Item Toronto Alexithymia Scale. IV. Reliability and factorial validity in different languages and cultures. J Psychosom Res. 2003;55:277-283.
58. Rampton D. Inflammatory Bowel Disease Clinical Diagnosis and Management. London: Martin Dunitz; 2000.
59. Altman DG. Practical Statistics for Medical Research. London: Chapman and Hall; 1991.
60. De Jong GM, van SE, Emmelkamp PM. A comprehensive model of stress, the roles of experienced stress and neuroticism in explaining the stress-distress relationship. Psychother Psychosom. 1999;68:290-298.